Table 1 Demographics, clinical and laboratory characteristics of migraine patients and controls
Migraine patients (n = 30) | Controls (n = 30) | P-value | ||
|---|---|---|---|---|
Age in years [median (IQR)] | 34.5 (27–43) | 36.5 (26–41) | 0.734 1 | |
Sex [n (%)] | Males | 8 (26.7%) | 7 (23.3%) | 0.766 2 |
Females | 22 (73.3%) | 23 (76.7%) | ||
Waist circumference in cm [mean (SD)] | 92.43 (11.14) | 84.9 (8.42) | 0.005* 3 | |
HTN [n (%)] | 5 (16.7%) | |||
Attack duration in hours [median (IQR)] | 12 (8- 13.75) | |||
Aura [n (%)] | 7 (23.3%) | |||
Autonomic manifestations [n (%)] | 2 (6.7%) | |||
Allodynia [n (%)] | 9 (30%) | |||
MIGSEV Scale [median (IQR)] | Intensity | 3 (2–3) | ||
Disability | 3 (2–3) | |||
Tolerability | 2 (1–2) | |||
Nausea | 2 (1–3) | |||
Total score | 2 (1–3) | |||
HIT-6 total score [median (IQR)] | 59 (49–64) | |||
Laboratory work up [mean (SD)] | FBS | 87.87 (12.19) | 86.8 (10.6) | 0.719 3 |
TGs | 97.4 (49.45) | 109.77 (37.97) | 0.282 3 | |
HDL | 50.51 (11.25) | 52.93 (10.76) | 0.397 3 | |
Insulin | 7.03 (2.997) | 5.37 (3.41) | 0.049* 3 | |
HOMA-IR | 1.72 (0.79) | 1.17 (0.81) | 0.01* 3 | |
Insulin resistance [n (%)] | 14 (46.7%) | 5 (16.7%) | 0.012* 2 | |
Metabolic syndrome [n (%)] | 13 (43.3%) | 5 (16.7%) | 0.024* 2 | |